These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23203181)

  • 41. Anaphylaxis to patent blue during sentinel lymph node biopsy.
    Ingram D; Hewett L; Maddern P
    ANZ J Surg; 2004 Jul; 74(7):607-8. PubMed ID: 15230805
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
    Aydogan F; Celik V; Uras C; Salihoglu Z; Topuz U
    Am J Surg; 2008 Feb; 195(2):277-8. PubMed ID: 18194680
    [No Abstract]   [Full Text] [Related]  

  • 43. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A retrospective analysis of rates of allergic reaction to Patent V blue dye used in sentinel lymph node biopsies for melanoma.
    Manton RN; Norrey M; Roshan A; Durrani AJ; Patel AJK
    J Plast Reconstr Aesthet Surg; 2022 Feb; 75(2):893-939. PubMed ID: 34840115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Allergic reaction to patent blue dye for sentinel lymph node detection during uterus oncological surgery].
    Noirot A; Vigneau A; Salengro A; Bonnet F
    Ann Fr Anesth Reanim; 2005 May; 24(5):541-2. PubMed ID: 15904733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anaphylaxis to patent blue dye--the benefit and the risk.
    Kollias J; Russell WJ
    Anaesth Intensive Care; 2011 Jul; 39(4):758-60; author reply 760. PubMed ID: 21826816
    [No Abstract]   [Full Text] [Related]  

  • 48. [Dangerous blue?].
    Varhaug JE
    Tidsskr Nor Laegeforen; 2011 May; 131(8):842. PubMed ID: 21556091
    [No Abstract]   [Full Text] [Related]  

  • 49. [Acute blue urticaria following subcutaneous injection of patent blue dye].
    Hamelin A; Vial-Dupuy A; Lebrun-Vignes B; Francès C; Soria A; Barete S
    Ann Dermatol Venereol; 2015 Nov; 142(11):670-4. PubMed ID: 26372548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
    Thevarajah S; Huston TL; Simmons RM
    Am J Surg; 2005 Feb; 189(2):236-9. PubMed ID: 15720998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urticaria due to patent blue V which appeared along the lymph flow.
    Kusutani N; Kamo R; Sowa-Osako J; Aoki A; Ishii M
    J Dermatol; 2013 Jun; 40(6):497-8. PubMed ID: 23442177
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hypersensitivity reaction after injection of patent blue V dye in saline for sentinal node detection].
    Alconchel Gonzaga SP; Fernández Amigo N; Perozo Limones M; Fernández Torres B; Casielles García JL; De las Mulas Béjar M
    Rev Esp Anestesiol Reanim; 2010 Nov; 57(9):607-9. PubMed ID: 21155347
    [No Abstract]   [Full Text] [Related]  

  • 53. Anaphylaxis to Patent Blue V. I. Clinical aspects.
    Hunting AS; Nopp A; Johansson SG; Andersen F; Wilhelmsen V; Guttormsen AB
    Allergy; 2010 Jan; 65(1):117-23. PubMed ID: 19793057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Near-fatal anaphylaxis to patent blue V.
    Wöhrl S; Focke M; Hinterhuber G; Stingl G; Binder M
    Br J Dermatol; 2004 May; 150(5):1037-8. PubMed ID: 15149528
    [No Abstract]   [Full Text] [Related]  

  • 55. Anaphylaxis and other adverse reactions to blue dyes: a case series.
    Howard JD; Moo V; Sivalingam P
    Anaesth Intensive Care; 2011 Mar; 39(2):287-92. PubMed ID: 21485680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic application of patent blue V in sentinel lymph node biopsy for breast cancer - Is it time for a change?
    Vidya R; Athwal R; Huissoon AP; Baretto RL; Thirumala Krishna M
    Indian J Cancer; 2019; 56(3):269-270. PubMed ID: 31389393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allergy to Blue Dye.
    Martín-Lázaro J; Núñez-Orjales R; Battikhi-Precedo N; López-Freire S; Carballada-González F
    J Investig Allergol Clin Immunol; 2016; 26(6):381-383. PubMed ID: 27996948
    [No Abstract]   [Full Text] [Related]  

  • 58. Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: case report and literature review.
    Efron P; Knudsen E; Hirshorn S; Copeland EM
    Breast J; 2002; 8(6):396-9. PubMed ID: 12390368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hypotension and oxygen saturation fall in a woman during sentinel lymph node biopsy].
    Johnsen L; Ilsaas C; Salthe J; Lende TH; Bjerkeset O; Søiland H
    Tidsskr Nor Laegeforen; 2011 May; 131(8):840-1. PubMed ID: 21556090
    [No Abstract]   [Full Text] [Related]  

  • 60. Anaphylaxis and patent Blue V.
    Pyke C
    Anaesth Intensive Care; 2011 Jul; 39(4):758; author reply 760. PubMed ID: 21823395
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.